Dedicare (DEDI) Q2 2025 earnings summary

Executive summary

• Net sales declined 20.0% year-over-year in Q2 2025 to SEK 351.7 million, with all markets weakening amid reduced demand and price pressure.

• EBITA margin narrowed to 3.7% (4.8%), with adjusted EBITA at SEK 14.0 million (24.1) due to non-recurring savings program costs.

• Cost savings program initiated, expected to yield SEK 20 million in annual savings from Q4 2025.

• Market share gains and investments in new segments like social care in Denmark and life science, despite challenging conditions.

Financial highlights

• Q2 2025 profit after financial items was SEK 11.7 million (19.6); profit for the period SEK 9.1 million (15.3).

• Basic and diluted EPS for Q2 were SEK 0.95 (1.60/1.59); for Jan-Jun, SEK 1.66 (2.70/2.67).

• Cash flow from operating activities in Q2 was SEK -33.3 million (1.2), mainly due to lower EBIT and delayed holiday liability payout in Norway.

• Equity/assets ratio improved to 49.8% (42.1%) as of 30 June 2025.

Outlook and guidance

• No clear signs of market improvement yet; company remains prepared for continued uncertainty.

• Full realization of cost savings program expected from Q4 2025.

• Continued focus on diversification and investment in high-potential segments.